Direct-to-consumer Genetic Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

Direct-to-consumer Genetic Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

The report on the global direct-to-consumer genetic testing market provides qualitative and quantitative analysis for the period from 2021-2030. The revenue generated by the market was USD 139.58 million in 2022 and is expected treach 800.45 million in 2030 with a CAGR of 21.2% till 2030, during the projected period 2023-2030. The study on direct-to-consumer genetic testing market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

Direct-to-consumer (DTC) genetic testing is a type of genetic testing that is offered tconsumers without a prescription or referral from a doctor. DTC genetic tests can be used tdetermine a person's genetic propensity for a number of ailments, such as diabetes, cancer, and heart disease. They can alsbe used tdiscover someone's family history. These tests are typically ordered online, and customers receive a testing kit at home, which usually involves providing a saliva or cheek swab sample. The sample is then sent back tthe testing company, and the results are provided directly tthe consumer through an online platform or app. The driving factor of the market is the increasing use of the internet consumers now have easier access tDTCGT services owing tthe penetration of the Internet. Companies can now market their goods tcustomers directly via online channels such as websites and social media.

Carrier testing is expected tgrab the highest share in the global market during the forecast period. Carrier testing basically focuses on identifying individuals carrying gene mutations that can be transmitted ttheir offspring, and this testing plays a crucial role in assessing the risk of passing on genetic disorders tfuture generations. It is particularly relevant for individuals with a family history of genetic conditions or those planning tstart a family. The continued dominance of carrier testing can be attributed tits significant value in family planning and reproductive decision-making. By obtaining information about carrier status, individuals can make informed choices and take necessary precautions treduce the likelihood of transmitting genetic disorders. Due tthese several factors is expected tgrab high shares in the global market.

North America is tgrab the highest share in the global market. This can be attributed tthe prevalent consumer attitudes towards genetic testing as the people here are more inclined towards health and aware of the diseases. Furthermore, the increase in expenditure further propels the growth of the demand for Direct-to-Consumer (DTC) genetic testing, which is expected tcontinue throughout the forecast period. The combination of consumer attitudes and increased expenditure contributes tthe market's dominance in North America, establishing it as a leading region in the global DTC genetic testing market. Moreover, the market growth in the region is expected tbe driven by the increasing number of product approvals and subsequent launches by the U.S. Food and Drug Administration (FDA). The FDA's role in approving and regulating genetic testing products will contribute tthe expansion of the market. Additionally, the high concentration of key players in the region actively involved in research activities tinnovate novel genetic testing products will further fuel market growth.

Report Findings

1) Drivers

Affordability and personalization, decreasing costs of DTC genetic tests have made them more accessible ta wider population, driving the growth of the market.

The appeal of having personalized insights and recommendations based on genetic information fuels the growth of the market.

2) Restraints

Concerns surrounding the confidentiality of genetic data restrain the market.

3) Opportunities

An opportunity for the market lies in rising pharmacogenetic research, as the field advances, DTC genetic testing companies can offer personalized insights inthow genetic factors influence an individual's response tmedications.

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

1. Key Opinion Leaders associated with Infinium Global Research

2. Internal and External subject matter experts

3. Professionals and participants from the industry

Our primary research respondents typically include

1. Executives working with leading companies in the market under review

2. Product/brand/marketing managers

3. CXO level executives

4. Regional/zonal/ country managers

5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications

2. Government/institutional publications

3. Trade and associations journals

4. Databases such as WTO, OECD, World Bank, and among others.

5. Websites and publications by research agencies

Segment Covered

The global direct-to-consumer genetic testing market is segmented on the basis of test type, technology type, and distribution channel.

The Global Direct-to-Consumer Genetic Testing Market by Test Type

Nutrigenomics Testing

Predictive Testing

Carrier Testing

Skincare Testing

Ancestry and Relationship Testing

The Global Direct-to-Consumer Genetic Testing Market by Technology Type

Target Analysis

Single Nucleotide Polymorphism (SNP) Chips

Whole Genome Sequencing (WGS)

The Global Direct-to-Consumer Genetic Testing Market by Distribution Channel

Online Platforms

Over-the-Counter

Company Profiles

The companies covered in the report include

Full Genomes Corporation, Inc.

EasyDNA

Color Health, Inc.

Gene by Gene, Ltd.

Helix OpCo, LLC

MyHeritage Ltd.

23andMe, Inc.

Genesis HealthCare

Ancestry

Other Companies

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the direct-to-consumer genetic testing market.

2. Complete coverage of all the segments in the direct-to-consumer genetic testing market tanalyze the trends, developments in the global market and forecast of market size up t2030.

3. Comprehensive analysis of the companies operating in the global direct-to-consumer genetic testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus tinvest, consolidate, expand and/or diversify.